Posts

[Book Review] The Protection of Traditional Knowledge at the Frontiers of Drug Discovery

"Competition Law in the Pharmaceutical Sector" returns to Brussels with IPKat readers’ discount

Beyond exclusion of pharmaceutical products from patentable subject matter as a solution to limited access to medicines in Africa

SPCs based on a second marketing authorisation - the fight continues (Novartis C-354/19)

BREAKING: CJEU delivers another blow to SPC owners in Abraxis Article 3(d) (or 1(b)) battle

Does Allergan's Saint Regis Mohawk Tribe transactional move "rip off consumers"?

The Evolution of U.S. Law and the Bio-Pharmaceutical Industry

AIPPI Congress Report 3: Biosimilars - into the great unknown?

Generics behaving badly? BMS v Teva illustrates UK judicial mood towards generic launch plans (Part II)

Generics behaving badly? BMS v Teva illustrates UK judicial mood towards generic launch plans (Part I)